SCHEMBL30935867

SCHEMBL30935867

O=c1[nH]c2nc3ccccc3n2c2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPA1 P27694 1/20 0.57
KDM4E B2RXH2 6/20 0.55
ALDH1A1 P00352 5/20 0.55
HPGD P15428 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
RAB9A P51151 4/20 0.52
LMNA P02545 2/20 0.52
HSD17B10 Q99714 2/20 0.52
NPC1 O15118 2/20 0.52
TP53 P04637 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
PKM P14618 1/20 0.52
MAPK10 P53779 1/20 0.49
ADORA1 P30542 2/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
PARP1 P09874 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15180301 1.00 RPA1 (0.57) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL30166463 0.87 KDM4E (0.49) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18053137 0.87 KDM4E (0.49) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22045669 0.84 KDM4E (0.45) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22045245 0.84 KDM4E (0.50) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22045665 0.84 KDM4E (0.50) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22045667 0.83 KDM4E (0.56) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20929343 0.80 KDM4E (0.57) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL13425234 0.78 KDM4E (0.53) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL13425232 0.78 RPA1 (0.49) RPA1KDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240147847-A1 ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2024-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240147847-A1 ELECTRONIC DEVICES NDUFS4, NDUFS3, NDUFS6 RPA1 3413/4885KDM4E 842/4885ALDH1A1 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.